Dozens of insurance companies filed a lawsuit under the Racketeer Influenced and Corrupt Organizations Act (RICO) against GlaxoSmithKline relating to adulterated drugs produced at the company’s factory in Cidra, Puerto Rico and distributed throughout the United States. The plaintiffs alleged the factory manufactured defective drugs and mixed up medications, and that Glaxo induced them into paying billions of dollars for the adulterated and falsely marketed drugs. Glaxo settled the lawsuit in November 2019. In 2010, Glaxo’s Puerto Rico subsidiary pleaded guilty to felony charges and paid $750 million in criminal and civil penalties relating to the manufacture and distribution of adulterated drugs produced at the facility between 2001 and 2005 (see GlaxoSmithKline instance “Puerto Rico Drug Manufacturing Facility Settlement”).